English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Technology/Innovation

+ Technology/Innovation
Robert Hadley | Jun 20, 2017

Novo Nordisk’s Xultophy better for diabetics than insulin alone, study says

+ Technology/Innovation
Carol Ostrow | Jun 19, 2017

UF study shows selexipag provides potential post-stroke protections

+ Technology/Innovation
Robert Hadley | Jun 19, 2017

U.S. clinical trial for chikungunya virus vaccine to begin

+ Technology/Innovation
Carol Ostrow | Jun 18, 2017

UW, Seattle genomics center researchers identify disease proteins

+ Technology/Innovation
Robert Hadley | Jun 18, 2017

Study may lead to development of Lassa vaccine

+ Technology/Innovation
Robert Hadley | Jun 16, 2017

Calithera says trials indicate new drug can inhibit growth of solid tumors

+ Technology/Innovation
Robert Hadley | Jun 16, 2017

Merck’s Keytruda shown effective in treating aggressive form of breast cancer

+ Technology/Innovation
Cheyenne Dickerson | Jun 16, 2017

Scientists hoping to better evaluate and treat kidney cancer with new laboratory models

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • « First
  • «
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily